T2 Biosystems, Inc.
TTOODelisted Jul 10, 2025- Industry
- Surgical & Medical Instruments & Apparatus
- SEC CIK
- 0001492674
T2 Biosystems, Inc. was delisted on Jul 10, 2025; its insiders filed their last Form 4 on Jan 2, 2025; 1 institution reported holding it in 13F filings for Q2 2025, worth $0 in total; no superinvestor held it.
13F holders, Q1 2025
Institutional positions in T2 Biosystems, Inc. as of Mar 31, 2025. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 2
- −24 vs. Q4 2024
- Shares held
- 2
- −871.8K (−100.0%) vs. Q4 2024
- Total value
- $0
- −$365.9K (−100.0%) vs. Q4 2024
- New holders
- 1
- 0 more added
- Sold out
- 25
- 0 more reduced
Compare with Q4 2024: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting TTOO on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 1 | $0 |
| Q1 2026 | 2 | $0 |
| Q4 2025 | 2 | $0 |
| Q3 2025 | 1 | $0 |
| Q2 2025 | 1 | $0 |
| Q1 2025 | 2 | $0 |
| Q4 2024 | 26 | $365.9K |
| Q3 2024 | 21 | $4.24M |
| Q2 2024 | 21 | $12.6M |
| Q1 2024 | 19 | $519.8K |
| Q4 2023 | 21 | $1.37M |
| Q3 2023 | 44 | $4.06M |
| Q2 2023 | 32 | $451.5K |
| Q1 2023 | 34 | $1.55M |
| Q4 2022 | 27 | $667.5K |
| Q3 2022 | 62 | $2.79M |
| Q2 2022 | 68 | $3.07M |
| Q1 2022 | 76 | $7.97M |
| Q4 2021 | 79 | $9.92M |
| Q3 2021 | 79 | $21.1M |
| Q2 2021 | 84 | $33.0M |
| Q1 2021 | 84 | $42.6M |
Institutions, Q1 2025
Shares, value and share of portfolio for each institution holding T2 Biosystems, Inc.; share changes are against Q4 2024.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Barclays PLC | 1 | $0 | 0.00% | 00.0% | Unchanged |
| Union Bancaire Privee, UBP SA | 1 | $0 | 0.00% | +1 | New |
| Vanguard Group Inc | 0 | $0 | 0.00% | −154,814−100.0% | Sold out |
| Geode Capital Management, LLC | 0 | $0 | 0.00% | −142,196−100.0% | Sold out |
| UBS Group AG | 0 | $0 | 0.00% | −139,240−100.0% | Sold out |
| Squarepoint Ops LLC | 0 | $0 | 0.00% | −92,983−100.0% | Sold out |
| BlackRock, Inc. | 0 | $0 | 0.00% | −76,827−100.0% | Sold out |
| State Street Corp | 0 | $0 | 0.00% | −63,743−100.0% | Sold out |
| Susquehanna International Group, LLP | 0 | $0 | 0.00% | −57,554−100.0% | Sold out |
| Virtu Financial LLC | 0 | $0 | 0.00% | −31,162−100.0% | Sold out |
| Northern Trust Corp | 0 | $0 | 0.00% | −27,142−100.0% | Sold out |
| Two Sigma Securities, LLC | 0 | $0 | 0.00% | −22,814−100.0% | Sold out |
| Kingswood Wealth Advisors, LLC | 0 | $0 | 0.00% | −20,000−100.0% | Sold out |
| Goldman Sachs Group Inc | 0 | $0 | 0.00% | −14,750−100.0% | Sold out |
| Two Sigma Investments, LP | 0 | $0 | 0.00% | −11,936−100.0% | Sold out |
| Nordwand Advisors, LLC | 0 | $0 | 0.00% | −10,000−100.0% | Sold out |
| Tower Research Capital LLC (TRC) | 0 | $0 | 0.00% | −5,304−100.0% | Sold out |
| Group One Trading, L.P. | 0 | $0 | 0.00% | −289−100.0% | Sold out |
| Citigroup Inc | 0 | $0 | 0.00% | −237−100.0% | Sold out |
| SBI Securities Co., Ltd. | 0 | $0 | 0.00% | −99−100.0% | Sold out |
| Bank of America Corp | 0 | $0 | 0.00% | −82−100.0% | Sold out |
| Advisor Group Holdings, Inc. | 0 | $0 | 0.00% | −38−100.0% | Sold out |
| JPMorgan Chase & Co | 0 | $0 | 0.00% | −33−100.0% | Sold out |
| Morgan Stanley | 0 | $0 | 0.00% | −14−100.0% | Sold out |
| US Bancorp | 0 | $0 | 0.00% | −3−100.0% | Sold out |
| Royal Bank of Canada | 0 | $0 | 0.00% | −271−100.0% | Sold out |
| CWM, LLC | 0 | $0 | 0.00% | −310−100.0% | Sold out |